Searched for
SPECTRUM PHARMACEUTICALS INC
Why Motilal Oswal’s BFSI fund is betting big on capital market ecosystem: Prateek Agarwal of Motilal Oswal AMC- Will the currency cycle help them? Yes, but very selectively: 10 pharma stocks with upside potential of up to 33%
- S&P 500, Dow Jones and NASDAQ move upwards as Wall Street swings through another unsettled day ahead of Nvidia’s profit report; WeShop Holdings gains nearly 450%, check top gainers and losers
- ASX closes day on positive side: Light & Wonder, Amcor among top gainers, James Hardie tops losers list; check top 5 gainers and losersThe ASX finished Thursday, November 6, 2025, on a high note. The S&P/ASX 200 index saw a gain of 0.30%. Major indices like the S&P/ASX 20, ...06 Nov, 2025, 01.01 PM IST
- Corrections are opportunities, if you enter the right sector and stocks: 5 stocks from pharma sector with an upside potential of up to 32%At a time when the Nifty and Sensex are trading with cuts in excess of 1%, talking of buying stocks may not appear quite right. But correct...03 Oct, 2024, 03.18 PM IST
- These healthcare and pharma stocks may deliver more than 20% in one yearCheck out Stock Reports Plus, powered by Refinitiv, for price targets of over 4,000 listed stocks along with detailed company analysis focu...18 Jun, 2024, 12.48 PM IST
- Nifty healthcare index stocks analysts suggest buying have potential upside of more than 19%Except for a pocket in which demand for covid drugs led to sharp surge in pharma stocks, the pharma sector had been under pressure for a lo...10 May, 2023, 01.13 PM IST
- Alembic Pharma gets USFDA nod for generic cancer drugAlembic Pharmaceuticals on Monday said it has received approval from the US health regulator to market a generic drug to treat cancer. The ...06 Mar, 2023, 11.59 AM IST
- Indian drug firm recalls eye drop linked to vision loss in USIn a statement posted on its website, Global Pharma Healthcare said it is notifying the distributors of this product Aru Pharma Inc and Del...03 Feb, 2023, 06.08 PM IST
- View: Warren Buffett likes stocks againThe disclosure of Berkshire’s Pfizer holding — valued at $138 million as of Monday’s close — comes a week after the drugmaker announced tha...17 Nov, 2020, 11.49 AM IST
- Aurobindo Pharma climbs 2% on new product acquisitionThe company hopes this acquisition will help it to enter the branded oncology market in the US.05 Mar, 2019, 04.00 PM IST
- Buy Aurobindo Pharma, target Rs 920: Phillip Capital (India)Buy Aurobindo Pharma at a price target of Rs 920.21 Jan, 2019, 05.51 PM IST
- Aurobindo acquires 7 oncology drugs from spectrum for $300 millionNasdaq-listed Spectrum Pharmaceuticals has carved out its commercial business inclusive of seven marketed oncology injectable products, int...18 Jan, 2019, 07.36 AM IST
- Pfizer acquires AstraZeneca's Neksium for Rs 75 croreNeksium was launched in India in the year 2006 and has developed strong equity with prescribers as a leading, high quality product in the A...01 Jun, 2017, 02.02 AM IST
- Top stocks in focus in Monday morning tradeMarkets are expected to turn rangebound after a sharp rally in previous session. Know the stocks which are likely to remain in focus.15 Jul, 2013, 09.41 AM IST
- CCI approves Nestle's acquisition of Pfizer nutrition businessCompetition watchdog CCI has approved Nestle's proposed acquisition of the global nutrition business of Pfizer.08 Aug, 2012, 07.04 PM IST
- NRI scientists who turned research into successful businessesNot many Indians in US would risk turning their scientific research into successful businesses. Here is the story of the bravehearts who di...23 Jul, 2012, 10.37 AM IST
- Lupin gets USFDA nod for anti-bacterial tablet"Levaquin tablets had annual sales of approximately USD 1.6 billion for the twelve months ended March, 2011, based on IMS Health sales data...22 Jun, 2011, 12.16 PM IST
- Read succeeds Kindler as Pfizer CEOIan C Read has been appointed as President and Chief Executive Officer (CEO) of Pfizer Inc, the US-based drug maker, succeeding Jeffrey B K...06 Dec, 2010, 03.07 PM IST
- Pfizer to snap up King Pharmaceuticals for $3.6 bnPfizer Inc on Tuesday said it will acquire King Pharmaceuticals in an all-cash deal worth $3.6 bn. The deal is expected to close in the Q4 ...12 Oct, 2010, 07.27 PM IST
Load More
